A case-control study between, cPLA2 polymorphism and schizophrenia (2000)
- Authors:
- USP affiliated authors: ELKIS, HELIO - FM ; GATTAZ, WAGNER FARID - FM ; VALLADA FILHO, HOMERO PINTO - FM
- Unidade: FM
- Subjects: ESQUIZOFRENIA; PSIQUIATRIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: American Journal of Medical Genetics
- ISSN: 0148-7299
- Volume/Número/Paginação/Ano: v. 96, n. 04, p. 534, res. P231, August, 2000
- Conference titles: World Congress on Psychiatric Genetics
-
ABNT
JUNIQUEIRA, R. et al. A case-control study between, cPLA2 polymorphism and schizophrenia. American Journal of Medical Genetics. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 03 jun. 2024. , 2000 -
APA
Juniqueira, R., Cordeiro, Q., Meira-Lima, I., Messas, G., Elkis, H., Gattaz, W. F., & Vallada Filho, H. P. (2000). A case-control study between, cPLA2 polymorphism and schizophrenia. American Journal of Medical Genetics. New York: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Juniqueira R, Cordeiro Q, Meira-Lima I, Messas G, Elkis H, Gattaz WF, Vallada Filho HP. A case-control study between, cPLA2 polymorphism and schizophrenia. American Journal of Medical Genetics. 2000 ; 96( 04): 534.[citado 2024 jun. 03 ] -
Vancouver
Juniqueira R, Cordeiro Q, Meira-Lima I, Messas G, Elkis H, Gattaz WF, Vallada Filho HP. A case-control study between, cPLA2 polymorphism and schizophrenia. American Journal of Medical Genetics. 2000 ; 96( 04): 534.[citado 2024 jun. 03 ] - Estudo de associação entre o polimorfismo alélico Ban I da fosfolipase A2 citosólica e esquizofrenia
- Investigation of possible association between Ser9Gly polymorphism of the D3 dopaminergic receptor gene and response to typical antipsychotics in patients with schizophrenia
- Association study between the dopamine d2 (taq polymorphism) and response to classical antipsychotics in schizophrenics
- Association study between the Ser-9-Gly polymorphism of the D3 dopaminergic receptor gene and response to conventional antipsychotics in patients with schizophrenia
- Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
- Decreased S100-beta protein in schizophrenia: preliminary evidence
- Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study
- Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability
- A double blind placebo controlled study of conjugated estrogens added to haloperidol in patients with schizophrenia
- Brasileiros estudam prevenção contra Alzheimer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas